Drug Shortage Report for BIO-OMEPRAZOLE
Report ID | 241101 |
Drug Identification Number | 02449927 |
Brand name | BIO-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | BIOMED PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-10-17 |
Actual start date | 2024-10-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-23 |
Company comments | Recherche de fournisseur alternatif |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-12-23 | English | Compare |
v5 | 2024-12-23 | English | Compare |
v4 | 2024-12-18 | French | Compare |
v3 | 2024-12-18 | English | Compare |
v2 | 2024-10-24 | French | Compare |
v1 | 2024-10-24 | English | Compare |
Showing 1 to 6 of 6